Hill-Rom Holdings Debt to Equity Ratio 2006-2018 | HRC

Current and historical debt to equity ratio values for Hill-Rom Holdings (HRC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Hill-Rom Holdings debt/equity for the three months ending September 30, 2018 was 1.11.
Hill-Rom Holdings Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $1.79B $1.62B 1.11
2018-06-30 $1.87B $1.51B 1.24
2018-03-31 $2.03B $1.51B 1.34
2017-12-31 $2.04B $1.46B 1.39
2017-09-30 $2.12B $1.37B 1.55
2017-06-30 $2.15B $1.29B 1.67
2017-03-31 $2.18B $1.25B 1.74
2016-12-31 $1.91B $1.20B 1.60
2016-09-30 $1.94B $1.24B 1.57
2016-06-30 $2.06B $1.20B 1.72
2016-03-31 $2.09B $1.18B 1.77
2015-12-31 $2.14B $1.15B 1.86
2015-09-30 $2.18B $1.16B 1.88
2015-06-30 $0.45B $0.77B 0.58
2015-03-31 $0.45B $0.72B 0.62
2014-12-31 $0.46B $0.74B 0.61
2014-09-30 $0.36B $0.81B 0.45
2014-06-30 $0.22B $0.83B 0.26
2014-03-31 $0.22B $0.80B 0.27
2013-12-31 $0.22B $0.84B 0.27
2013-09-30 $0.23B $0.86B 0.26
2013-06-30 $0.23B $0.81B 0.29
2013-03-31 $0.23B $0.81B 0.29
2012-12-31 $0.24B $0.82B 0.29
2012-09-30 $0.24B $0.81B 0.29
2012-06-30 $0.05B $0.81B 0.06
2012-03-31 $0.05B $0.80B 0.06
2011-12-31 $0.05B $0.77B 0.07
2011-09-30 $0.05B $0.74B 0.07
2011-06-30 $0.05B $0.75B 0.07
2011-03-31 $0.05B $0.76B 0.07
2010-12-31 $0.05B $0.73B 0.07
2010-09-30 $0.10B $0.71B 0.14
2010-06-30 $0.10B $0.68B 0.15
2010-03-31 $0.10B $0.65B 0.15
2009-12-31 $0.10B $0.63B 0.16
2009-09-30 $0.10B $0.61B 0.16
2009-06-30 $0.10B $0.60B 0.17
2009-03-31 $0.10B $0.58B 0.17
2008-12-31 $0.10B $1.06B 0.10
2008-09-30 $0.10B $1.08B 0.09
2008-06-30 $0.10B $1.08B 0.09
2008-03-31 $0.13B $1.05B 0.12
2007-12-31 $0.35B $1.31B 0.27
2007-09-30 $0.35B $1.28B 0.27
2007-06-30 $0.35B $1.26B 0.28
2007-03-31 $0.35B $1.22B 0.29
2006-12-31 $0.35B $1.17B 0.30
2006-09-30 $0.35B $1.13B 0.31
2006-06-30 $0.35B $1.07B 0.32
2006-03-31 $0.35B $1.04B 0.33
2005-12-31 $0.35B $1.00B 0.35
2005-09-30 $0.35B $0.97B 0.36
2005-06-30 $0.35B $1.12B 0.32
2005-03-31 $0.35B $1.14B 0.31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.323B $2.470B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $128.221B 19.17
Abbott Laboratories (ABT) United States $126.175B 25.57
Stryker (SYK) United States $64.233B 24.21
Boston Scientific (BSX) United States $50.592B 25.57
Baxter (BAX) United States $35.222B 22.75
Zimmer Biomet Holdings (ZBH) United States $22.847B 14.82
Smith & Nephew SNATS (SNN) United Kingdom $16.598B 0.00
ResMed (RMD) United States $16.236B 30.96
Perrigo (PRGO) Ireland $7.946B 12.06
Canopy Growth (CGC) Canada $7.699B 0.00
Bio-Rad Laboratories (BIO) United States $7.552B 48.29
Aurora Cannabis (ACB) Canada $5.910B 31.21
Haemonetics (HAE) United States $5.336B 46.93
Insulet (PODD) United States $4.873B 0.00
ICU Medical (ICUI) United States $4.821B 26.86
Hutchison China MediTech (HCM) China $4.050B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.710B 0.00
Neogen (NEOG) United States $3.247B 49.17
Agios Pharmaceuticals (AGIO) United States $3.172B 0.00
NuVasive (NUVA) United States $2.911B 27.09
National Vision Holdings (EYE) United States $2.497B 48.30
Quidel (QDEL) United States $2.014B 26.26
NxStage Medical (NXTM) United States $1.931B 0.00
Aphria (APHA) $1.534B 0.00
Phibro Animal Health (PAHC) United States $1.321B 18.70
AtriCure (ATRC) United States $1.182B 0.00
Cardiovascular Systems (CSII) United States $1.013B 1457.00
VAREX IMAGING (VREX) United States $0.925B 18.53
PetIQ (PETQ) United States $0.844B 21.86
Surmodics (SRDX) United States $0.784B 119.47
Meridian Bioscience (VIVO) United States $0.783B 24.96
Cerus (CERS) United States $0.753B 0.00
OraSure Technologies (OSUR) United States $0.733B 41.24
Omeros (OMER) United States $0.709B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.658B 21.10
Lantheus Holdings (LNTH) United States $0.652B 20.18
MacroGenics (MGNX) United States $0.600B 0.00
NanoString Technologies (NSTG) United States $0.534B 0.00
LeMaitre Vascular (LMAT) United States $0.512B 25.14
Owens & Minor (OMI) United States $0.443B 5.01
Quanterix (QTRX) United States $0.429B 0.00
TG Therapeutics (TGTX) United States $0.418B 0.00
Insys Therapeutics (INSY) United States $0.376B 0.00
Evolus (EOLS) United States $0.355B 0.00
Utah Medical Products (UTMD) United States $0.329B 21.25
VAPOTHERM INC (VAPO) United States $0.317B 0.00
Cytosorbents (CTSO) United States $0.278B 0.00
Bovie Medical (BVX) United States $0.240B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.240B 0.00
Surface Oncology (SURF) United States $0.238B 0.00
BioLife Solutions (BLFS) United States $0.213B 288.50
Chimerix (CMRX) United States $0.174B 0.00
Rockwell Medical (RMTI) United States $0.173B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.139B 0.00
Fonar (FONR) United States $0.132B 6.65
Chembio Diagnostics (CEMI) United States $0.107B 0.00
United-Guardian (UG) United States $0.079B 16.60
Female Health (VERU) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.064B 17.87
CAS Medical Systems (CASM) United States $0.055B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.039B 0.00
Myomo (MYO) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Senestech (SNES) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00